Trial Profile
Cerebrum and Cardiac Protection With Allopurinol in Neonates With Critical Congenital Heart Disease Requiring Cardiac Surgery With Cardiopulmonary Bypass
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 05 Jun 2023
Price :
$35
*
At a glance
- Drugs Allopurinol (Primary) ; Mannitol
- Indications Congenital heart defects
- Focus Therapeutic Use
- Acronyms CRUCIAL
- 23 Feb 2022 Trial design published in the Trials
- 13 Jan 2020 Status changed from not yet recruiting to recruiting.
- 04 Dec 2018 New trial record